Events

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. With some now considering […]

As AMR emerges, new strategies for the treatment of infection and identification of resistant microbes are crucial. This JPIAMR activity, led by the UK Medical Research Council (MRC) with support from South Africa (SAMRC), Korea (NRF), France (ANR), and Canada (CIHR) is delivered as part of JPIAMR’s mission to enable global coordination of research. The […]

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. With some […]

FDA, NIAID and CDC are announcing a public workshop regarding the development considerations of antimicrobial drugs for the treatment of gonorrhea. The workshop will focus on the current state and nonclinical and clinical trial design considerations regarding antimicrobial drug development for gonorrhea and include the following topic areas: Animal models Clinical pharmacology considerations Trial design […]

This course is designed to increase the knowledge of managing patients with CF across the lifespan of all who interact with this population. About this Event The target audience includes nurses, respiratory therapists, physical and occupational therapists, social workers, dieticians, child life specialists, and physicians Click here to learn more and register.

Delivering our 2021 Virtual Network Conference in an innovative online format will provide a unique opportunity to hear about the latest bacterial vaccinology research from leading international researchers in a safe environment. Talks will be delivered by a host of internationally renowned speakers from a range of disciplines, all actively involved in the research area […]

Additional details forthcoming. Click here to learn more.  

Speaker: Aleksandar Danilovski, Chief Scientific Officer, Xellia Pharmaceuticals (Denmark) Moderator: TBC Aleksandar's presentation will discuss: Are CMC and formulation efforts treated as the foster child in the innovation and development armament? Underestimating CMC and formulation aspects can potentially cause significant delays and project failures Appropriate (what, how and when) CMC and formulation innovation and development […]

For the past 20 years, the World Vaccine Congress Washington congress has evolved and grown into the leading vaccines congress globally, with hundreds of speakers, thousands of attendees and hundreds of networking opportunities. Our event format allows for whole-sector topics, giving an opportunity for people to find out more about their specific area of research […]

Join the Duke-Margolis Center for Health Policy—including an introduction by former FDA Commissioners Dr. Mark McClellan and Dr. Scott Gottlieb—for an important discussion on combating rising antimicrobial resistance (AMR) in the context of U.S. public health preparedness, support for novel antibiotics, global AMR policy leadership, and emerging multi-sector innovation. Rising antimicrobial resistance remains a top global […]